Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 12 August 2026
What it is about
Adagene SafebodyCorey DavisPeter LebowitzPeter LuoRaymond TamNasdaqTerms Of ServiceEuropean UnionUnited StatesLinkedinAdagene IncExchange CommissionJohnson JohnsonDevelopment R D ExpensesAmerican Association For Cancer ResearchDynamic Precision LibraryMerck Sharp DohmeAmericanManila, Manila, PhilippinesSuzhou, Jiangsu, China
Who published it, and when
How it spread - 1 original report
Wed, 12 August 2026
1 report- manilatimes.net11:38first to report
Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been established